Derivative exercise or conversion — not an open-market buy.
Traded Jul 23, 2026 · Filed Jul 27, 2026
Charles Schwab Corporation's General Counsel sold $709K of Charles Schwab Corporation shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$709,341
Shares × reported transaction price
2 days after results of Jul 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $101.61 on Jul 23, 2026, 19% above its 52-week low and 5% below its high, after a 14% rise over the previous 30 trading days
52-week range $85.35 (May 28, 2026) to $107.21 (Feb 9, 2026), 74% of the way up, from 251 adjusted closes. 30 trading days earlier: $88.77 on Jun 9, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 6, 2025 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
Lewis v. Charles Schwab & Co., Inc., docket 4:25-cv-01086, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.4% | +4.1% | -3.8% |
| 30 days | +2.0% | +4.1% | -2.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
787K → 610K shares held−22% of their stake
Charles Schwab Corporation's Co-Chairman sold $20M of Charles Schwab Corporation shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.